WO1994003102A1 - Optical monitor (oximeter, etc.) with motion artefact suppression - Google Patents
Optical monitor (oximeter, etc.) with motion artefact suppression Download PDFInfo
- Publication number
- WO1994003102A1 WO1994003102A1 PCT/GB1993/001630 GB9301630W WO9403102A1 WO 1994003102 A1 WO1994003102 A1 WO 1994003102A1 GB 9301630 W GB9301630 W GB 9301630W WO 9403102 A1 WO9403102 A1 WO 9403102A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- photodetector
- wavelengths
- signals
- different
- Prior art date
Links
- 230000033001 locomotion Effects 0.000 title claims abstract description 26
- 230000003287 optical effect Effects 0.000 title claims abstract description 9
- 230000001629 suppression Effects 0.000 title description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 10
- 239000001301 oxygen Substances 0.000 claims abstract description 10
- 239000008280 blood Substances 0.000 claims abstract description 9
- 210000004369 blood Anatomy 0.000 claims abstract description 9
- 238000012545 processing Methods 0.000 claims description 12
- 238000012806 monitoring device Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 238000012544 monitoring process Methods 0.000 abstract description 4
- 230000005540 biological transmission Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002106 pulse oximetry Methods 0.000 description 2
- 238000004148 unit process Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
- A61B5/7214—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using signal cancellation, e.g. based on input of two identical physiological sensors spaced apart, or based on two signals derived from the same sensor, for different optical wavelengths
Definitions
- OPTICAL MONITOR OXIMETER, ETC.
- This invention relates to an optical monitoring or measuring device with motion artefact suppression.
- Motion artefact is a significant problem in pulse oximeters, and can render these devices inoperative for up to
- an optical measuring or monitoring device which comprises light source means for emitting one or more light beams which includes light of a plurality of different wavelengths, photodetector means for receiving said light beam or beams after passing through or being reflected within living tissue and arranged to provide signals corresponding to the intensities of the respective wavelengths received by the photodetector means, the arrangement being such that the quiescent (or "DC") signal levels corresponding to the different wavelengths bear a predetermined relationship with each other, and signal processing means for processing the output signals from the photodetector means to cancel out variations due to motion artefact and to provide an output representing a parameter to be measured or monitored and substantially unaffected by motion artefact.
- light source means for emitting one or more light beams which includes light of a plurality of different wavelengths
- photodetector means for receiving said light beam or beams after passing through or being reflected within living tissue and arranged to provide signals corresponding to the intensities of the respective wavelengths received by the photodetector means, the arrangement being such that the qui
- a pulse oximetry device For example, in a pulse oximetry device, light of two or more wavelengths is passed through or reflected within living tissue. At each wavelength, there is a fixed “DC” intensity of light received by the photodetector, with a pulsatile “AC” component (caused by arterial pulsation) superimposed thereon.
- a pulse oximeter uses two wavelengths and the signal processing unit processes the signals from the photodetector, corresponding to these two wavelengths, to provide a measure of pulse rate or blood oxygen saturation.
- the signal processing unit processes the three signals from the photodetector firstly to cancel out the motion artefact and then to determine the pulse rate and/or blood oxygen saturation.
- a device In general, where a device normally uses n different wavelengths of light and processes the n corresponding output signals from the photodetector to determine the value of the parameter being measured or monitored, in accordance with this invention the device will use an additional wavelength (n + 1) wavelengths altogether, so that the motion artefact can be cancelled out.
- n + 1) wavelengths Preferably high accuracy readings are made by the controller of each of the three sources via a single sensor and a single hardware conversion block. From these readings, three difference signals are produced. Because these (AC) difference signals have reduced motion artefact signal and directly reflect the different absorption levels in the tissue, they can be used in combination as indicators of the oxygen saturation level.
- Preferably additional real time digital filtering of the signals is used to reduce 50/60Hz components and to correlate input signals to improve noise rejection.
- the input channels may be continuously monitored by the processor to ensure that the effects of component aging or temperature drifting are eliminated.
- Preferably most of the signal processing is performed in software so the costs of the unit is low and there is no requirement for very accurate hardware matching.
- the device comprises three LED's 1,2,3 emitting different wavelengths of light for transmission through or reflection from within living tissue, indicated schematically at T.
- the device further comprises photodetectors 11,12,13 for receiving each of the transmitted or reflected light beams.
- the device includes a control means 20, arranged to adjust the power applied to the LED's, to give a "DC" signal level, in the outputs from the photodetectors 11,12,13, which is equal for all three wavelengths: this can be achieved very accurately. Then:
- the OAC's are the observed AC signals from the photodetector, the AC'S are the true AC signals, and MA is the motion artefact.
- the device further includes a signal processor 30, in which:
- OAC ⁇ l is subtracted from OAC ⁇ 2, giving AC ⁇ l - AC ⁇ 2;
- OAC ⁇ 2 is subtracted from OAC ⁇ 3, giving AC ⁇ 2 - AC ⁇ 3
- the signal processing unit then extracts the original AC components in accordance with the following:
- Equation 8 Rearranging Equation 8 to quadratic form :
- Equation 9 a
- Equation 9 b
- %Sa02 F. AC ⁇ 2 + K4. AC ⁇ 3
- the motion artefact signals differ from each other by 5 to 20% implying a degree of rejection of between 20 and 5 times. How close this figure is to 0% depends on the severity of the physical disturbance causing the artefact, and probably on the sensor design.
- the light source at all wavelengths are point sourced, that is they originate as far as their path through the medium is concerned at a single point.
- the configuration of the light sources is constrained by the physical dimensions of the sources, i.e. they are as close as is physically possible.
- a light guide method may be used to make all light sources originate from a single point.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Signal Processing (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
An optical device, particularly for pulse rate and/or blood oxygen saturation monitoring, comprises a light source (1, 2, 3) emitting light at three different wavelengths, and a photodetector (11, 12, 13) for receiving the light after transmission through or reflection within living tissue (T) to produce signals corresponding to the intensities of the respective wavelengths received by the photodetector. The arrangement is such that the quiescent (or 'DC') levels in the three output signals are substantially equal. A signal processor forms two signals representing the differences between two different pairs of the three outputs from the photodetector, to eliminate variations (motion artefact) due to movement of the subject. The two difference signals are further processed to extract the AC components in the photodetector outputs, from which pulse rate and blood oxygen saturation can be determined.
Description
OPTICAL MONITOR (OXIMETER, ETC.) WITH MOTION ARTEFACT SUPPRESION
This invention relates to an optical monitoring or measuring device with motion artefact suppression.
Medical instruments are being developed which use non- invasive optical techniques. As is well known in the art, these instruments suffer interference due to patient movement, motion artefact.
For example it is known, in order to measure blood oxygen saturation, to provide a device which passes light through the human finger and monitors the output signal of a photodetector of this device continuously. Movement of the subject leads to changes in the light path and hence to variations in the intensity of light received by the photodetector. This renders the device incapable of distinguishing between changes in received light intensity caused by variations in light absorption by the component being monitored (e.g. oxygen in the blood) , and changes in received light intensity caused by variations in the light path due to movement of the subject.
Motion artefact is a significant problem in pulse oximeters, and can render these devices inoperative for up to
40% of the monitoring period in certain clinical applications. The problem is common to all optical monitoring devices and is particularly severe in critical health care applications, where continuous monitoring is essential. We have now devised an optical measuring or monitoring device which is able to suppress the effects of motion artefact.
In accordance with this invention, there is provided an optical measuring or monitoring device which comprises light source means for emitting one or more light beams which includes light of a plurality of different wavelengths, photodetector means for receiving said light beam or beams after passing through or being reflected within living tissue and arranged to provide signals corresponding to the intensities of the respective wavelengths received by the photodetector means, the arrangement being such that the quiescent (or "DC") signal levels corresponding to the
different wavelengths bear a predetermined relationship with each other, and signal processing means for processing the output signals from the photodetector means to cancel out variations due to motion artefact and to provide an output representing a parameter to be measured or monitored and substantially unaffected by motion artefact.
For example, in a pulse oximetry device, light of two or more wavelengths is passed through or reflected within living tissue. At each wavelength, there is a fixed "DC" intensity of light received by the photodetector, with a pulsatile "AC" component (caused by arterial pulsation) superimposed thereon.
Theoretically, and as confirmed by experiment, variations in signal output due to motion artefact (changes in source-to-tissue and photodetector-to-tissue coupling) are proportional to the respective "DC" signal level. Thus, if the DC intensity of light at the photodetector were doubled, for instance by doubling the output of the light source, a given degree of mechanical disturbance to the device would produce double the motion artefact variation in the detector output signal. Thus if the DC signals are equal at the different wavelengths, the amplitude of the motion artefact signal components will be the same for all those wavelengths.
Normally a pulse oximeter uses two wavelengths and the signal processing unit processes the signals from the photodetector, corresponding to these two wavelengths, to provide a measure of pulse rate or blood oxygen saturation. In accordance with this invention, such a pulse oximeter uses three wavelengths: the signal processing unit processes the three signals from the photodetector firstly to cancel out the motion artefact and then to determine the pulse rate and/or blood oxygen saturation.
In general, where a device normally uses n different wavelengths of light and processes the n corresponding output signals from the photodetector to determine the value of the parameter being measured or monitored, in accordance with this invention the device will use an additional wavelength (n + 1) wavelengths altogether, so that the motion artefact can be cancelled out.
Preferably high accuracy readings are made by the controller of each of the three sources via a single sensor and a single hardware conversion block. From these readings, three difference signals are produced. Because these (AC) difference signals have reduced motion artefact signal and directly reflect the different absorption levels in the tissue, they can be used in combination as indicators of the oxygen saturation level.
Preferably additional real time digital filtering of the signals is used to reduce 50/60Hz components and to correlate input signals to improve noise rejection.
The input channels may be continuously monitored by the processor to ensure that the effects of component aging or temperature drifting are eliminated. Preferably most of the signal processing is performed in software so the costs of the unit is low and there is no requirement for very accurate hardware matching.
An embodiment of this invention will now be described by way of example only and with reference to the accompanying drawings, the single figure of which is a diagrammatic block diagram of a device in accordance with this invention.
Referring to the drawing, there is shown a pulse oximetry and blood oxygen saturation monitoring device. The device comprises three LED's 1,2,3 emitting different wavelengths of light for transmission through or reflection from within living tissue, indicated schematically at T. The device further comprises photodetectors 11,12,13 for receiving each of the transmitted or reflected light beams. The device includes a control means 20, arranged to adjust the power applied to the LED's, to give a "DC" signal level, in the outputs from the photodetectors 11,12,13, which is equal for all three wavelengths: this can be achieved very accurately. Then:
the OAC's are the observed AC signals from the photodetector, the AC'S are the true AC signals, and MA is the motion artefact.
The device further includes a signal processor 30, in which:
OAC λl is subtracted from OAC λ2, giving ACλl - ACλ2; and
OAC λ2 is subtracted from OAC λ3, giving ACλ2 - ACλ3
In this manner, the motion artefact signals are subtracted out. There is a known relationship between the values of ACλl and ACλ2 and ACλ3 of the general form :
ACλl + Kl = K4. ACλ2 + K2 Equation 1
ACλ2 + K2 ACλ3 + K3
in which the K's are known constants for the three wavelengths used. The signal processing unit then extracts the original AC components in accordance with the following:
Let K5 = OACλl - 0ACλ2 = ACλl - ACλ2 Equation 2
Let K6 = OACλ2 - 0ACλ3 = ACλ2 - ACλ3 Equation 3
Let Al, A2 and A3 equal ACλl, ACλ2 and ACλ3 ~
From equations 2 and 3 : Al = K5 + A2 Equation 4 and A3 = A2 - K6 Equation 5
Replacing Al and A3 in equation 1 using Equations 4 and 5 :
K5 + A2 + Kl = K4. A2 + K2 Equation 6
A2 + K2 A2 - K6 + K3
Cross-multiplying Equation 6 :
(K5 + A2 + Kl) . (A2 - K6 + K3) = K4 (A2 + K2)2 Equation 7
Multiplying out the first pair of brackets in Equation 7 :
A2 + (K5 + Kl - K6 + K3) A2 + [ (K5 + Kl) (K3 - K6) ] = K4 A22 + 2K4. K2. A2 + K4. K22 Equation 8
Rearranging Equation 8 to quadratic form :
(K4 -1). A22 + (2K4. K2. + K6 - K3 - K5 - Kl) A2 +
K4. K22 - [(K5 + Kl) (K3 - K6) ] = 0 Equation 9
Let the first term in Equation 9 = a Let the second term in Equation 9 = b Let the third term in Equation 9 = c
A2 = ACλ2 = -b ±Vfb2 - 4ac)
2a and from Equations 4 and 5 : ACλl = K5 + ACλ2 and ACλ3 = ACλ2 - K6
Since Kl, K2, K3 and K4 are fixed and known for the three wavelengths in use and K5 and K6 are measured, the processing unit is able to recover the three original "AC" components. It may readily be shown that, where F is a simple function :
ACλl
%SA02 = F. DCλl
ACλ2 DCλ2 for a two wavelength oximetry system.
For a three wavelength system, this modifies by direct analogy to :
ACλl ACλ2 %Sa02 = F DCλl +K4. DCλ2
ACλ2 ACλ3
DCλ2 DCλ3 wherein K4 has the same value as previously.
This effectively takes the mean of two wavelength pairs to obtain the blood oxygen saturation % Sa 02.
Since the DC levels are the same in this case, the formula simplifies to :
ACλl ACλ2
%Sa02 = F. ACλ2 + K4. ACλ3
With the "DC" level equalisation in the three light channels and the motion artefact signals therefore identical, it is theoretically possible to null out the motion artefact entirely. In practice, under many circumstances, the motion artefact signals differ from each other by 5 to 20% implying a degree of rejection of between 20 and 5 times. How close this figure is to 0% depends on the severity of the physical disturbance causing the artefact, and probably on the sensor design. The light source at all wavelengths are point sourced, that is they originate as far as their path through the medium is concerned at a single point.
The configuration of the light sources is constrained by the physical dimensions of the sources, i.e. they are as close as is physically possible. Alternatively, a light guide method may be used to make all light sources originate from a single point.
Claims
Claims
1) An optical measuring or monitoring device which comprises light source means (1,2,3) for emitting one or more light beams which include light of a plurality of different wavelengths, photodetector means (11,12,13) for receiving said light beam or beams after passing through or being reflected within living tissue (T) and arranged to provide signals corresponding to the intensities of the respective wavelengths received by the photodetector means (11,12,13) , the arrangement being such that the quiescent (or "DC" signal levels corresponding to the different wavelengths bear a predetermined relationship with each other, and signal processing means (30) for processing the output signals from the photodetector means (11,12,13) to cancel out variations due to motion artefact and to provide an output representing a parameter to be measured or monitored and substantially unaffected by motion artefact.
2) A device as claimed in claim 1 in which said quiescent (or "DC") signal levels in the outputs from the photodetector means, corresponding to different said wavelengths of light, are all substantially equal to each other.
3) A device as claimed in claim 2, in which the signal processing means (30) is arranged to form two signals representing the differences between two different pairs of three outputs from the photodetector means (20) , corresponding to three different said wavelengths of light.
4) A device as claimed in claim 3, in which the signal processing means (30) is further arranged to process _ ,id two difference signals to extract the AC component of at least one output from the photodetector means (20) .
5) A device as claimed in claim 4, in which the signal processing means (30) is further arranged to determine blood oxygen saturation of the living tissue (T) from ratios of two different pairs of said AC components extracted from three outputs of said photodetector means (20) , corresponding to
three different said wavelengths of light.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU47198/93A AU4719893A (en) | 1992-08-01 | 1993-08-02 | Optical monitor (oximeter, etc.) with motion artefact suppression |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9216431.8 | 1992-08-01 | ||
GB929216431A GB9216431D0 (en) | 1992-08-01 | 1992-08-01 | Optical monitoring or measuring artefact suppression |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994003102A1 true WO1994003102A1 (en) | 1994-02-17 |
Family
ID=10719722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1993/001630 WO1994003102A1 (en) | 1992-08-01 | 1993-08-02 | Optical monitor (oximeter, etc.) with motion artefact suppression |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU4719893A (en) |
GB (1) | GB9216431D0 (en) |
WO (1) | WO1994003102A1 (en) |
ZA (1) | ZA935579B (en) |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5517988A (en) * | 1993-12-11 | 1996-05-21 | Hewlett-Packard Company | Method for detecting an irregular state in a non-invasive pulse oximeter system |
EP0733340A1 (en) * | 1995-03-23 | 1996-09-25 | Seiko Instruments Inc. | Pulse rate monitor |
GB2300045A (en) * | 1995-04-11 | 1996-10-23 | Yoav Paltieli | Optical fibre endoscope |
WO1997000041A1 (en) * | 1995-06-14 | 1997-01-03 | Nellcor Puritan Bennett Incorporated | Method and apparatus for removing motion artifact and noise from pulse oximetry |
DE19609410A1 (en) * | 1996-03-04 | 1997-09-11 | Biotronik Mess & Therapieg | Device for determining blood oxygen saturation |
WO1997036538A1 (en) * | 1996-04-01 | 1997-10-09 | Kontron Instruments Ag | Detection of parasitic signals during pulsoxymetric measurement |
WO1998004903A1 (en) * | 1996-07-26 | 1998-02-05 | Kontron Instruments Ag | Method of non-invasive determination of oxygen saturation in tissue in which blood is circulating |
DE19647877A1 (en) * | 1996-11-19 | 1998-05-28 | Metrax Gmbh | Method for determining oxygen saturation in blood |
WO1999032030A1 (en) | 1997-12-22 | 1999-07-01 | Btg International Limited | Artefact reduction in photoplethysmography |
WO2000009004A2 (en) | 1998-08-13 | 2000-02-24 | Whitland Research Limited | Optical device |
US6104938A (en) * | 1996-06-12 | 2000-08-15 | Instrumentarium Oy | Procedure, apparatus and detector for the determination of fractional oxygen saturation |
EP1297784A1 (en) | 2001-09-28 | 2003-04-02 | C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa | Method and device for pulse rate detection |
WO2003077756A1 (en) * | 2002-03-19 | 2003-09-25 | Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie Nauchno-Issledovatelskiy Institut 'polyus' | Physiological method for defining the state of biological tissue (variants) and diagnostic system for carrying out said method |
US6658277B2 (en) | 2001-09-13 | 2003-12-02 | Imagyn Medical Technologies, Inc. | Signal processing method and device for signal-to-noise improvement |
US6801799B2 (en) | 2000-10-05 | 2004-10-05 | Cybro Medical, Ltd. | Pulse oximeter and method of operation |
WO2005087098A1 (en) * | 2004-03-09 | 2005-09-22 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
US6997879B1 (en) | 2002-07-09 | 2006-02-14 | Pacesetter, Inc. | Methods and devices for reduction of motion-induced noise in optical vascular plethysmography |
WO2006097437A1 (en) | 2005-03-14 | 2006-09-21 | Spectrum Medical Llp | Monitoring of predetermined substances in blood |
WO2008042147A2 (en) * | 2006-09-29 | 2008-04-10 | Nellcor Puritan Bennett Llc | Symmetric led array for pulse oximetry |
US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
US7738935B1 (en) | 2002-07-09 | 2010-06-15 | Pacesetter, Inc. | Methods and devices for reduction of motion-induced noise in pulse oximetry |
US7774037B2 (en) | 1998-07-04 | 2010-08-10 | Whitland Research Limited | Non-invasive measurement of blood analytes |
US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US8315685B2 (en) | 2006-09-27 | 2012-11-20 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
US8600469B2 (en) | 2005-09-29 | 2013-12-03 | Covidien Lp | Medical sensor and technique for using the same |
US8708900B2 (en) | 2007-12-26 | 2014-04-29 | Covidien Lp | LED drive circuit and method for using same |
US8862194B2 (en) | 2008-06-30 | 2014-10-14 | Covidien Lp | Method for improved oxygen saturation estimation in the presence of noise |
US8930145B2 (en) | 2010-07-28 | 2015-01-06 | Covidien Lp | Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring |
US8965473B2 (en) | 2005-09-29 | 2015-02-24 | Covidien Lp | Medical sensor for reducing motion artifacts and technique for using the same |
USD736250S1 (en) | 2008-06-30 | 2015-08-11 | Covidien Lp | Portion of a display panel with an indicator icon |
US9326731B2 (en) | 2011-03-25 | 2016-05-03 | Nitto Denko Corporation | Method of measuring an artefact removed photoplethysmographic (PPG) signal and a measurement system |
US9351674B2 (en) | 2005-03-03 | 2016-05-31 | Covidien Lp | Method for enhancing pulse oximetry calculations in the presence of correlated artifacts |
WO2016166290A1 (en) * | 2015-04-15 | 2016-10-20 | Koninklijke Philips N.V. | Optical laser speckle sensor for measuring a blood perfusion parameter |
CN106248579A (en) * | 2016-08-31 | 2016-12-21 | 马东阁 | A kind of OLED blood testing equipment |
WO2017055307A1 (en) * | 2015-09-28 | 2017-04-06 | Koninklijke Philips N.V. | Vital signs sensor and method of measuring vital signs of a user |
US9833146B2 (en) | 2012-04-17 | 2017-12-05 | Covidien Lp | Surgical system and method of use of the same |
US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
US10022058B2 (en) | 2006-09-28 | 2018-07-17 | Covidien Lp | System and method for pulse rate calculation using a scheme for alternate weighting |
US10076276B2 (en) | 2008-02-19 | 2018-09-18 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US10426360B2 (en) | 2013-05-15 | 2019-10-01 | Pulseon Oy | Portable pulse measuring device |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN740796A0 (en) * | 1996-01-04 | 1996-01-25 | Circuitry Systems Limited | Biomedical data collection apparatus |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4266554A (en) * | 1978-06-22 | 1981-05-12 | Minolta Camera Kabushiki Kaisha | Digital oximeter |
EP0102816A2 (en) * | 1982-09-02 | 1984-03-14 | Nellcor Incorporated | Pulse oximeter |
WO1988001147A1 (en) * | 1986-08-18 | 1988-02-25 | Physio-Control Corporation | Feedback-controlled method and apparatus for processing signals used in oximetry |
EP0286142A2 (en) * | 1987-04-09 | 1988-10-12 | Sumitomo Electric Industries, Ltd. | Reflection type oximeter |
EP0303502A1 (en) * | 1987-08-14 | 1989-02-15 | Btg International Limited | Motion artefact rejection system for pulse oximeters |
US4819752A (en) * | 1987-10-02 | 1989-04-11 | Datascope Corp. | Blood constituent measuring device and method |
EP0479322A2 (en) * | 1990-10-03 | 1992-04-08 | Spacelabs, Inc. | Apparatus for detecting transducer movement |
US5190038A (en) * | 1989-11-01 | 1993-03-02 | Novametrix Medical Systems, Inc. | Pulse oximeter with improved accuracy and response time |
-
1992
- 1992-08-01 GB GB929216431A patent/GB9216431D0/en active Pending
-
1993
- 1993-08-02 WO PCT/GB1993/001630 patent/WO1994003102A1/en active Application Filing
- 1993-08-02 ZA ZA935579A patent/ZA935579B/en unknown
- 1993-08-02 AU AU47198/93A patent/AU4719893A/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4266554A (en) * | 1978-06-22 | 1981-05-12 | Minolta Camera Kabushiki Kaisha | Digital oximeter |
EP0102816A2 (en) * | 1982-09-02 | 1984-03-14 | Nellcor Incorporated | Pulse oximeter |
WO1988001147A1 (en) * | 1986-08-18 | 1988-02-25 | Physio-Control Corporation | Feedback-controlled method and apparatus for processing signals used in oximetry |
EP0286142A2 (en) * | 1987-04-09 | 1988-10-12 | Sumitomo Electric Industries, Ltd. | Reflection type oximeter |
EP0303502A1 (en) * | 1987-08-14 | 1989-02-15 | Btg International Limited | Motion artefact rejection system for pulse oximeters |
US4819752A (en) * | 1987-10-02 | 1989-04-11 | Datascope Corp. | Blood constituent measuring device and method |
US5190038A (en) * | 1989-11-01 | 1993-03-02 | Novametrix Medical Systems, Inc. | Pulse oximeter with improved accuracy and response time |
EP0479322A2 (en) * | 1990-10-03 | 1992-04-08 | Spacelabs, Inc. | Apparatus for detecting transducer movement |
Cited By (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5517988A (en) * | 1993-12-11 | 1996-05-21 | Hewlett-Packard Company | Method for detecting an irregular state in a non-invasive pulse oximeter system |
US5749366A (en) * | 1995-03-23 | 1998-05-12 | Seiko Instruments Inc. | Motion compensating pulse rate monitor with motion sensor and level discriminator |
EP0733340A1 (en) * | 1995-03-23 | 1996-09-25 | Seiko Instruments Inc. | Pulse rate monitor |
EP1506735A3 (en) * | 1995-03-23 | 2005-05-04 | Seiko Instruments Inc. | A method of monitoring a pulse rate |
GB2300045A (en) * | 1995-04-11 | 1996-10-23 | Yoav Paltieli | Optical fibre endoscope |
GB2300045B (en) * | 1995-04-11 | 1999-06-09 | Yoav Paltieli | Optical-fiber type endoscope |
US5645060A (en) * | 1995-06-14 | 1997-07-08 | Nellcor Puritan Bennett Incorporated | Method and apparatus for removing artifact and noise from pulse oximetry |
WO1997000041A1 (en) * | 1995-06-14 | 1997-01-03 | Nellcor Puritan Bennett Incorporated | Method and apparatus for removing motion artifact and noise from pulse oximetry |
DE19609410A1 (en) * | 1996-03-04 | 1997-09-11 | Biotronik Mess & Therapieg | Device for determining blood oxygen saturation |
DE19609410C2 (en) * | 1996-03-04 | 2002-04-25 | Biotronik Mess & Therapieg | Device for determining blood oxygen saturation |
WO1997036538A1 (en) * | 1996-04-01 | 1997-10-09 | Kontron Instruments Ag | Detection of parasitic signals during pulsoxymetric measurement |
US6181959B1 (en) | 1996-04-01 | 2001-01-30 | Kontron Instruments Ag | Detection of parasitic signals during pulsoxymetric measurement |
US6104938A (en) * | 1996-06-12 | 2000-08-15 | Instrumentarium Oy | Procedure, apparatus and detector for the determination of fractional oxygen saturation |
WO1998004903A1 (en) * | 1996-07-26 | 1998-02-05 | Kontron Instruments Ag | Method of non-invasive determination of oxygen saturation in tissue in which blood is circulating |
US6151107A (en) * | 1996-07-26 | 2000-11-21 | Linde Medical Sensors Ag | Method of non-invasive determination of oxygen saturation in tissue in which blood is circulating |
DE19647877A1 (en) * | 1996-11-19 | 1998-05-28 | Metrax Gmbh | Method for determining oxygen saturation in blood |
DE19647877C2 (en) * | 1996-11-19 | 2000-06-15 | Univ Ilmenau Tech | Method and circuit arrangement for determining the oxygen saturation in the blood |
WO1999032030A1 (en) | 1997-12-22 | 1999-07-01 | Btg International Limited | Artefact reduction in photoplethysmography |
US7774037B2 (en) | 1998-07-04 | 2010-08-10 | Whitland Research Limited | Non-invasive measurement of blood analytes |
US7236813B2 (en) | 1998-08-13 | 2007-06-26 | Edwards Lifesciences Corporation | Optical device |
US7221970B2 (en) | 1998-08-13 | 2007-05-22 | Edwards Lifesciences Corporation | Optical device |
WO2000009004A2 (en) | 1998-08-13 | 2000-02-24 | Whitland Research Limited | Optical device |
WO2000009004A3 (en) * | 1998-08-13 | 2000-06-02 | Whitland Res Ltd | Optical device |
US6842635B1 (en) | 1998-08-13 | 2005-01-11 | Edwards Lifesciences Llc | Optical device |
EP1598003A3 (en) * | 1998-08-13 | 2006-03-01 | Whitland Research Limited | Optical device |
EP1598003A2 (en) | 1998-08-13 | 2005-11-23 | Whitland Research Limited | Optical device |
US6801799B2 (en) | 2000-10-05 | 2004-10-05 | Cybro Medical, Ltd. | Pulse oximeter and method of operation |
US6658277B2 (en) | 2001-09-13 | 2003-12-02 | Imagyn Medical Technologies, Inc. | Signal processing method and device for signal-to-noise improvement |
US7027850B2 (en) | 2001-09-13 | 2006-04-11 | Conmed Corporation | Signal processing method and device for signal-to-noise improvement |
US7060035B2 (en) | 2001-09-13 | 2006-06-13 | Conmed Corporation | Signal processing method and device for signal-to-noise improvement |
EP1297784A1 (en) | 2001-09-28 | 2003-04-02 | C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa | Method and device for pulse rate detection |
WO2003077756A1 (en) * | 2002-03-19 | 2003-09-25 | Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie Nauchno-Issledovatelskiy Institut 'polyus' | Physiological method for defining the state of biological tissue (variants) and diagnostic system for carrying out said method |
US7738935B1 (en) | 2002-07-09 | 2010-06-15 | Pacesetter, Inc. | Methods and devices for reduction of motion-induced noise in pulse oximetry |
US6997879B1 (en) | 2002-07-09 | 2006-02-14 | Pacesetter, Inc. | Methods and devices for reduction of motion-induced noise in optical vascular plethysmography |
US7277741B2 (en) | 2004-03-09 | 2007-10-02 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
WO2005087098A1 (en) * | 2004-03-09 | 2005-09-22 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
US9351674B2 (en) | 2005-03-03 | 2016-05-31 | Covidien Lp | Method for enhancing pulse oximetry calculations in the presence of correlated artifacts |
WO2006097437A1 (en) | 2005-03-14 | 2006-09-21 | Spectrum Medical Llp | Monitoring of predetermined substances in blood |
US8965473B2 (en) | 2005-09-29 | 2015-02-24 | Covidien Lp | Medical sensor for reducing motion artifacts and technique for using the same |
US8600469B2 (en) | 2005-09-29 | 2013-12-03 | Covidien Lp | Medical sensor and technique for using the same |
US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
US8315685B2 (en) | 2006-09-27 | 2012-11-20 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
US10022058B2 (en) | 2006-09-28 | 2018-07-17 | Covidien Lp | System and method for pulse rate calculation using a scheme for alternate weighting |
US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
WO2008042147A3 (en) * | 2006-09-29 | 2008-05-22 | Nellcor Puritan Bennett Llc | Symmetric led array for pulse oximetry |
WO2008042147A2 (en) * | 2006-09-29 | 2008-04-10 | Nellcor Puritan Bennett Llc | Symmetric led array for pulse oximetry |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8708900B2 (en) | 2007-12-26 | 2014-04-29 | Covidien Lp | LED drive circuit and method for using same |
US10076276B2 (en) | 2008-02-19 | 2018-09-18 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US11298076B2 (en) | 2008-02-19 | 2022-04-12 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
USD736250S1 (en) | 2008-06-30 | 2015-08-11 | Covidien Lp | Portion of a display panel with an indicator icon |
US8862194B2 (en) | 2008-06-30 | 2014-10-14 | Covidien Lp | Method for improved oxygen saturation estimation in the presence of noise |
US8930145B2 (en) | 2010-07-28 | 2015-01-06 | Covidien Lp | Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring |
US9326731B2 (en) | 2011-03-25 | 2016-05-03 | Nitto Denko Corporation | Method of measuring an artefact removed photoplethysmographic (PPG) signal and a measurement system |
US9833146B2 (en) | 2012-04-17 | 2017-12-05 | Covidien Lp | Surgical system and method of use of the same |
US10426360B2 (en) | 2013-05-15 | 2019-10-01 | Pulseon Oy | Portable pulse measuring device |
WO2016166290A1 (en) * | 2015-04-15 | 2016-10-20 | Koninklijke Philips N.V. | Optical laser speckle sensor for measuring a blood perfusion parameter |
WO2017055307A1 (en) * | 2015-09-28 | 2017-04-06 | Koninklijke Philips N.V. | Vital signs sensor and method of measuring vital signs of a user |
CN107847167A (en) * | 2015-09-28 | 2018-03-27 | 皇家飞利浦有限公司 | The method of the vital sign of vital sign sensors and measurement user |
JP2018533390A (en) * | 2015-09-28 | 2018-11-15 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Vital sign sensor and method of measuring vital sign of user |
RU2680190C1 (en) * | 2015-09-28 | 2019-02-18 | Конинклейке Филипс Н.В. | Sensor of indicators of vital important functions and method of measurement of indicators of vital life important functions of user |
US10376164B2 (en) | 2015-09-28 | 2019-08-13 | Koninklijke Philips N.V. | Vital signs sensor and method of measuring vital signs of a user |
CN106248579A (en) * | 2016-08-31 | 2016-12-21 | 马东阁 | A kind of OLED blood testing equipment |
Also Published As
Publication number | Publication date |
---|---|
AU4719893A (en) | 1994-03-03 |
ZA935579B (en) | 1994-02-02 |
GB9216431D0 (en) | 1992-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994003102A1 (en) | Optical monitor (oximeter, etc.) with motion artefact suppression | |
US5277181A (en) | Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis | |
JP3925945B2 (en) | A method for measuring oxygen saturation in tissues that are supplied with blood without damaging the specimen | |
US6163715A (en) | Direct to digital oximeter and method for calculating oxygenation levels | |
US4824242A (en) | Non-invasive oximeter and method | |
EP0290272A1 (en) | Examination apparatus for measuring oxygenation | |
EP3590425B1 (en) | Multi-wavelength physiological monitor | |
EP0335357B1 (en) | Improved method and apparatus for detecting optical pulses | |
EP0870465B1 (en) | Method and apparatus for the non-invasive determination of the concentration of a component | |
US5193543A (en) | Method and apparatus for measuring arterial blood constituents | |
US5431159A (en) | Pulse oximetry | |
US4883353A (en) | Pulse oximeter | |
US7606606B2 (en) | Patient monitoring device with multiple sensors | |
EP0549835A1 (en) | Diagnostic apparatus | |
JPH11192217A (en) | Method and device for reducing artifact signal level in physiological signal | |
JPS63252239A (en) | Reflection type oxymeter | |
JPH0371135B2 (en) | ||
JP2000507465A (en) | False signal detection method in pulse oximetry | |
EP0271340B1 (en) | Oximeter apparatus and method for measuring arterial blood constituents | |
JPH05269116A (en) | Improved artery blood monitor device | |
JP6373511B2 (en) | Optical analysis system and method | |
EP0290273A1 (en) | Examination apparatus for measuring oxygenation | |
EP0290278A1 (en) | Examination apparatus for measuring oxygenation | |
JP2004148069A (en) | Reflection type detector for degree of blood oxygen saturation | |
EP3434182B1 (en) | System for monitoring the blood supply to the transplanted organ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA GB JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |